Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 39.38
-0.67 (-1.67%)
Aug 14, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 12.54 billion as of August 14, 2026. Its market cap has decreased by -17.95% in one year.
Market Cap
12.54B
Enterprise Value
10.24B
Revenue
2.89B
Ranking
n/a
PE Ratio
12.89
Stock Price
39.38
ChartMarket Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 12.54B, an increase of 765.68%. That is a compound annual growth rate of 8.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 12.54B | -8.60% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 13.66B |
| Wedge Industrial | 13.63B |
| Nanjing King-Friend Biochemical Pharmaceutical | 13.04B |
| PharmaBlock Sciences (Nanjing) | 12.76B |
| Beijing Aosaikang Pharmaceutical | 12.75B |
| Zhejiang Medicine | 12.64B |
| Zhejiang CONBA Pharmaceutical | 12.18B |
| Guobang Pharma | 11.99B |